Skip to main content
Oxford University Press - PMC COVID-19 Collection logoLink to Oxford University Press - PMC COVID-19 Collection
. 2020 Jun 25;27(5):taaa102. doi: 10.1093/jtm/taaa102

A cluster of COVID-19 in pilgrims to Israel

Androula Pavli1, Paraskevi Smeti1, Kalliopi Papadima2, Anastasia Andreopoulou2, Sofia Hadjianastasiou1, Eleni Triantafillou2, Annita Vakali3, Chrysovalantou Kefaloudi3, Danai Pervanidou3, Charalambos Gogos4, Helena C Maltezou5,
PMCID: PMC7337872  PMID: 32584403

Short Communication

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China in December 2019 that causes a respiratory disease named coronavirus disease 2019 (COVID-19) was declared by the World Health Organization on 11 March 2020 a pandemic. Mass gatherings with high intensity social contacts have been a well-recognized risk factor for the transmission of infectious diseases, including SARS-CoV-2, as shown by recent reports in returning pilgrims.1–4 Therefore, and in the interests of global safety, many mass gatherings have been suspended as a response to the pandemic.5

The aim of this report is to describe a cluster of SARS-CoV-2 infections in Christian pilgrims returning from Israel to Greece in late February 2020, after their pilgrimage at Jerusalem holy place, a mass gathering attended by a large number of people. In Greece, the first COVID-19 case was diagnosed in Thessaloniki (Northern Greece) on February 26 in a traveler returning from Italy. Similarly, in Israel there were only two imported cases and in Egypt one case reported at that time.

On 3 March 2020, two COVID-19 cases were notified to the National Public Health Organization among pilgrims returning from Jerusalem on 27 February 2020 with a direct flight from Tel Aviv, Israel. Both cases were symptomatic during the flight. These two cases were part of a large group of 53 pilgrims which visited Jerusalem on February 19. Their trip also included visits to Jericho, Mount Sinai in Egypt and Bethlehem from 19 to 27 February 2020, common activities, transportation in the same buses and residing in the same hotels. Upon arrival to Athens, the group was transferred to their final destinations to Peloponnese by bus and to an Ionian island by bus and later by ship.

Following the notification of the two COVID-19 cases, extensive contact tracing was carried out of all passengers and crew members of the same flight; five additional COVID-19 cases were diagnosed among close contacts (four passengers not belonging to the same group and one crew member). Guidelines were provided to all close contacts (group of pilgrims, tour guides, all passengers and crew members) for a 14-day self-quarantine following their last exposure, self-monitoring for fever and/or respiratory symptoms, and for contacting the National Public Health Organization’s hotline for further advice in case of symptoms onset. In addition, the travel agent was informed in order to notify travel agencies in Israel and Egypt to take relevant public health measures.

All 53 pilgrims were tested for SARS-CoV-2 by RT-PCR 7 days after their arrival upon notification of the two COVID-19 cases. Of them, 48 (90.5%) were tested positive. Table 1 shows the characteristics of the 48 positive cases. All 48 pilgrims were Greek nationals, with a female-to-male ratio of 2.2 (33 women and 15 men). Their mean age was 58 years (range: 29–84 years) and 18 (37.5%) were 65 years of age and older. Twelve pilgrims (25%) had an underlying condition. Overall, 41 (85.4%) of the 48 positive cases developed symptoms consistent with COVID-19 while 7 (14.6%) remained asymptomatic (Table 1). Onset of symptoms occurred up to 9 days after return. Fever, cough, sore throat, weakness, dyspnea, rhinorrhea and gastrointestinal symptoms were recorded in 30 (73.2%), 27 (65.8%), 8 (19.5%), 6 (14.6%), 5 (12.2%), 4 (9.7%) and 3 (7.3%) of the 41 symptomatic cases, respectively. Investigation with a chest imaging test was performed in 13 (27%) of all positive cases of whom 7 (53.8%) had findings compatible with pneumonia. Twenty pilgrims required hospitalization, including two cases admitted in the intensive care unit. Overall, eight of hospitalized pilgrims developed complications. Two pilgrims died because of COVID-19; all others had an uneventful recovery. Self-isolation and health monitoring for 14 days was recommended to the five pilgrims who were tested negative; repeat tests were also negative. It is worth mentioning that a Greek tour bus driver of the pilgrim group in Israel was also infected.6

Table 1.

Characteristics of 48 pilgrims with SARS-CoV-2 infection

NoSymptom onsetImaging testUnderlying conditionsComplicationsHospitalizationOutcome
129/02/2020YesHypertension, atrial fibrillationARDS, MODS, ARFICUDead
204/03/2020YesNilNoWardRecovery
329/02/2020YesCOPDPneumoniaWardRecovery
427/02/2020NoMultiple sclerosisNo-Recovery
529/02/2020NoNilNo-Recovery
629/02/2020NoNilNo-Recovery
7N/ANoNilNo-Recovery
802/03/2020NoNilNo-Recovery
903/03/2020NoNilNo-Recovery
1003/03/2020NoNilNo-Recovery
1126/02/2020NoCVD, malignancyPneumoniaWardRecovery
1201/03/2020NoNilNo-Recovery
1329/02/2020NoAtrial fibrillationNo-Recovery
1406/03/2020NoNilNoWardRecovery
1527/02/2020YesNilARDS, MODSICUDead
1602/03/2020YesBronchial asthmaN/AWardRecovery
1726/02/2020YesNilPneumoniaWardRecovery
1801/03/2020NoHypertensionNo-Recovery
1902/03/2020YesMyelodysplastic syndromePneumoniaWardRecovery
2003/03/2020NoNilNo-Recovery
2103/03/2020N/ANilNoWardRecovery
2201/03/2020NoNilNoWardRecovery
23N/ANoNilNo-
2404/03/2020YesNilNoWardRecovery
25N/AN/ANilNo-Recovery
2603/03/2020YesNilPneumoniaWardRecovery
2727/02/2020N/ANilNoWardRecovery
2828/02/2020YesNilNo-Recovery
29N/ANoNilNo-Recovery
3025/02/2020N/ANilNo-Recovery
3125/02/2020NoNilNo-Recovery
3225/02/2020NoNilNo-Recovery
3328/02/2020NoNilNo-Recovery
34N/ANoNilNo-Recovery
3501/03/2020NoNilNoWardRecovery
3629/02/2020YesNilPneumoniaWardRecovery
37N/ANoNilNo-Recovery
3829/02/2020NoHypertensionNo-Recovery
3928/02/2020NoNilNoWardRecovery
40N/ANoNilNo-Recovery
4128/02/2020NoRheumatoid arthritisNo-Recovery
42N/ANoNo-Recovery
4328/02/2020NoHypertensionNoWardRecovery
4426/02/2020NoHeart failureNo-Recovery
4504/03/2020NoNilNo-Recovery
46N/AYesNilNo-Recovery
4729/02/2020NoNilNoWardRecovery
4806/03/2020YesNilNoWardRecovery

ARDS: acute respiratory distress syndrome, ARF: acute renal failure, COPD: chronic obstructive pulmonary disease, CVD: cardiovascular disease, ICU: intensive care unit, M: male, MODS: multiple organ dysfunction syndrome, N/A: non applicable and SARS-CoV-2: severe acute respiratory syndrome coronavirus 2.

Containment measures including contact tracing and isolation implemented at that time seemed to be effective to prevent disease spread in the local community. Considering the low possibility of local transmission at destinations and also at the country of origin due to low prevalence in origin and destination countries, it is possible that the pilgrims were infected during religious rituals by other SARS-CoV-2 infected travelers from countries where local transmission was already established.1 Based on the results of our study, these cases suggested a high risk of SARS-CoV-2 infection for pilgrims traveling during the pandemic. A large proportion of these pilgrims were 65 years of age and older with underlying conditions. This explains their high complication rate and case fatality rate.7 The high attack rate among this group of pilgrims, is probably related to potential risk behaviours during pilgrimage, such as exposure to crowded conditions with pilgrims from different countries and also engagement in common activities, including religious rituals and also recreational activities for a long period of time.1 A similar outbreak was reported among South Korean nationals who were tested positive for SARS-CoV-2 infection after they visited the West Bank from February 9 to 14 as a group of 77 members; however, no evidence was found of connection leading to transmission between the two groups.8

Mass gatherings, including pilgrimage, are a risk factor for rapid spread of respiratory infections which is the most common disease among pilgrims. Crowded conditions and intensity of social contacts during their engagement in religious rituals may lead to propagation and amplification of this novel respiratory virus SARS-CoV-2.1 As the pandemic continues, there will be an increasing number of pilgrims returning back home. SARS-CoV-2 may be seeded in and transmitted out of holy places by visitors. Therefore, it is strongly recommended that the home countries should be prepared to receive such cases, and therefore to implement appropriate public health measures.9 Public health authorities should increase awareness in pilgrims about the risks and the need for personal protection. Pilgrims should be advised adherence to hygiene recommendations, to avoid close contact with sick people and to report and seek healthcare if they become symptomatic after pilgrimage.10 Travel health professionals must be aware of the risks posed by returned pilgrims. Preventive measures before departure and on the field should be reinforced during pre-travel consultation. Postponement may be recommended in particular for elderly pilgrims and those with chronic and underlying conditions.

Acknowledgement

We thank Athanasios Minitsios and Panagiota Isari from the Department of Travel Medicine of the National Public Health Organization for their administrative and data management support.

Authors’ Contributions

Androula Pavli: investigation, writing, review, editing. Paraskevi Smeti: investigation, writing and review. Sofia Hadjianastasiou: Investigation and review. Kalliopi Papadima: investigation, editing and review. Anastasia Andreopoulou: investigation and review. Danai Pervanidou: investigation and review. Chrysovalantou Kefaloudi: investigation and review. Anita Vakali: investigation and review. Charalambos Gogos: investigation, writing and review. Helena C. Maltezou: investigation, writing, review and editing.

Funding

No funding was received for this work.

Conflict of Interest

There is no conflict of interest to declare.

References


Articles from Journal of Travel Medicine are provided here courtesy of Oxford University Press

RESOURCES

close